Munafa Stock Market Course + Intraday & FNO calls 
C NEWS why is Citigroup Inc. price falling or rising
C NEWS reasons for why stock price of Citigroup Inc. is falling or rising
C Citigroup Inc is falling or rising technical reasons
Technical analysis forecast of Citigroup Inc Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Citigroup Inc C at this time. Stock is rising and might rise more.
It appears as if Citigroup Inc C gave a large move recently.
Stock of Citigroup Inc (C) is trading above an important moving average line, but it crossed this line recently, which means that it could show a small or a large fall soon enough depending on its trend.
My analysis of Citigroup Inc is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if Citigroup Inc stays above 120.8, but if it comes below 120.8, then a intra day sell could be more profitable.
If you take a sell trade below 120.8, then use 120.8 as stoploss and 117.73 as target. However if you take a buy trade in Citigroup Inc, then use 120.8 as stoploss and 124.5 as target.
C Citigroup Inc is falling or rising NEWS fundamental reasons
Logic Infotech reports standalone net profit of Rs 0.01 crore in the December 2025 quarter Reported sales nil - NEWS as on 2026-02-11 business-standard.com
ARC Finance reports standalone net loss of Rs 0.01 crore in the December 2025 quarter Sales rise 14.89% to Rs 0.54 crore - NEWS as on 2026-02-10 business-standard.com
Apollo Hospitals Q3 net profit jumps 35% on strong organic growth Apollo Hospitals Enterprises reported a 35% rise in consolidated net profit in Q3FY26, driven by organic growth across hospitals, HealthCo and lifestyle businesses, with margins improving - NEWS as on 2026-02-10 business-standard.com
Marico to acquire 75% equity stake in Vietnamese DTC firm Skinetiq The FMCG major will acquire a 75% stake in Vietnam-based Skinetiq in an all-cash deal valued at Rs 350 crore, strengthening its premium beauty and D2C play in the market - NEWS as on 2026-02-09 business-standard.com
Genpharmasec reports consolidated net loss of Rs 0.83 crore in the December 2025 quarter Sales rise 369.69% to Rs 39.83 crore - NEWS as on 2026-02-09 business-standard.com
ONGC opens 4,000-seat convention centre in Goa, eyes Filmfare-scale events Overlooking the Arabian Sea and just a 15-minute ferry ride away from leading beachside resorts, a 4,000-seat convention centre has been built in pristine south Goa to host large conferences and marquee events, including Filmfare-scale award functions. Sta - NEWS as on 2026-02-08 business-standard.com
GIC Re Q3 result: Profit falls 6% to ?1,519 cr; income rises to ?11,557 cr GIC Re on Saturday reported a 6 per cent drop in net profit to Rs 1,519 crore for the third quarter ended December 2025. The state-owned reinsurance company earned a net profit of Rs 1,621 crore in the October-December period of the last fiscal. Total inco - NEWS as on 2026-02-07 business-standard.com
DMCC Speciality Chemicals consolidated net profit declines 21.60% in the December 2025 quarter Sales rise 27.81% to Rs 150.87 crore - NEWS as on 2026-02-06 business-standard.com
LIC Q3 Results: Cons PAT jumps 17% YoY to Rs 12,930 crore, net premium income also up 17% LIC Q3 Results: LIC reported a 17% YoY rise in Q3 consolidated profit to Rs 12,930 crore, supported by higher premium income and improved VNB margins. Despite a slight dip in policy sales, APE, solvency ratio and AUM all strengthened, while non-par product - NEWS as on 2026-02-05 indiatimes.com
IOC Q3 net profit soars six times on higher GRMs, LPG compensation IOC's revenue from operations rose 7.7 per cent to Rs 2.36 lakh crore in the quarter ended December 2025 - NEWS as on 2026-02-05 business-standard.com
Nykaa Q3 Results Preview: PAT may surge up to 192% YoY led by BPC momentum; revenue to rise up to 28% Nykaa is poised for a strong performance in the December quarter. Robust festive demand and sustained momentum in its Beauty and Personal Care segment are expected to drive significant profit growth. Brokerage estimates project a substantial surge in net p - NEWS as on 2026-02-04 indiatimes.com
TREVOC group, Canonicus Capital to set up Rs 500cr fund for NCR realty projects Realty firm TREVOC Group has partnered with Canonicus Capital to set up a Rs 500 crore last-mile funding and execution platform for near-completion real estate projects in Delhi-NCR. - NEWS as on 2026-02-03 indiatimes.com
NSE IPO: Temasek, LIC said to plan share sales in nearly Rs 23,000 crore issue Temasek Holdings and Life Insurance Corporation of India are poised to be major sellers in the National Stock Exchange of India's potential .5 billion IPO. State Bank of India and SBI Capital Markets are also expected to participate in the offering, whic - NEWS as on 2026-02-02 indiatimes.com
Pre-Market Earnings Report for February 3, 2026 : MRK, PFE, ETN, TDG, ITW, EPD, MPLX, MPC, AME, GWW, PYPL, ADM The following companies are expected to report earnings prior to market open on 02/03/2026. Visit our Earnings Calendar for a full list of expected earnings releases.Merck & Company, Inc. (MRK)is reporting for the quarter ending December 31, 2025. The - NEWS as on 2026-02-02 nasdaq.com
Why Elastic Could Be the Next AI Winner in 2026 Elastic N.V. (NYSE: ESTC) is known for its search and analytics tools that make AI-powered data organization possible. Its Elasticsearch product allows users to quickly complete full-text searches across petabytes of both structured and unstructured d - NEWS as on 2026-01-30 nasdaq.com
NTPC Green Energy Q3 Results: Net profit plunges 74% YoY to Rs 17.32 crore NTPC Green Energy Ltd, or NGEL, saw its net profit drop significantly by 74 percent in the December quarter. This decline to Rs 17.32 crore was caused by a sharp rise in expenses. Despite this, the company's total income grew to Rs 684.22 crore. NGEL is NT - NEWS as on 2026-01-30 indiatimes.com
Bristol Myers moves SC to stop Zydus from selling biosimilar cancer drug US firm Bristol Myers Squibb is in the Supreme Court seeking to halt Zydus Lifesciences from manufacturing and selling a biosimilar cancer drug. The court will hear the appeal on February 4. BMS markets the drug nivolumab under brands Opdivo and Opdyta. - NEWS as on 2026-01-30 indiatimes.com
Thermo Fisher Scientific Q4 25 Earnings Conference Call At 8:30 AM ET (RTTNews) - Thermo Fisher Scientific (TMO) will host a conference call at 8:30 AM ET on January 29, 2026, to discuss Q4 25 earnings results. - NEWS as on 2026-01-29 nasdaq.com
Allied Blenders and Distillers Q3 PAT up 11 pc at Rs 63.74 cr Allied Blenders and Distillers Ltd on Thursday reported an 11 per cent rise in consolidated profit after tax at Rs 63.74 crore in the third quarter ended December 31, 2025, aided by lower expenses. - NEWS as on 2026-01-29 indiatimes.com
More announcements and NEWS
C Citigroup Inc. current price & indicator signals
Recent prices of C Citigroup Inc. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 10 Tue Feb 2026 | 122.15 | 119.50 to 125.00 | -1.31% | 1.07 times |
| 09 Mon Feb 2026 | 123.77 | 121.69 to 125.16 | 0.9% | 1.14 times |
| 06 Fri Feb 2026 | 122.66 | 115.72 to 122.97 | 5.98% | 0.87 times |
| 05 Thu Feb 2026 | 115.74 | 112.92 to 116.41 | -1.44% | 1.65 times |
| 04 Wed Feb 2026 | 117.43 | 116.93 to 119.94 | -0.24% | 1.09 times |
| 03 Tue Feb 2026 | 117.71 | 115.38 to 118.92 | 1.29% | 0.65 times |
| 02 Mon Feb 2026 | 116.21 | 114.40 to 116.98 | 0.43% | 0.58 times |
| 30 Fri Jan 2026 | 115.71 | 114.18 to 116.65 | 0.44% | 1.09 times |
| 29 Thu Jan 2026 | 115.20 | 113.40 to 116.36 | 0.91% | 1.27 times |
| 28 Wed Jan 2026 | 114.16 | 113.14 to 115.71 | -0.55% | 0.6 times |
| 27 Tue Jan 2026 | 114.79 | 113.70 to 115.97 | -0.03% | 1.06 times |
| 26 Mon Jan 2026 | 114.82 | 113.16 to 115.48 | 1.06% | 0.49 times |
Videos related to: C NEWS why is Citigroup Inc. price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance
